Halozyme Therapeutics
HALO
#2051
Rank
NZ$13.28 B
Marketcap
$107.90
Share price
1.16%
Change (1 day)
60.87%
Change (1 year)

Halozyme Therapeutics (HALO) - P/B ratio

P/B ratio as of March 2025 : 20.9

According to Halozyme Therapeutics's latest financial reports the company has a price-to-book ratio of 7.50536.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Halozyme Therapeutics - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3116.8-71.11%
2023-12-3158.328.57%
2022-12-3145.357.64%
2021-12-3128.7-24.8%
2020-12-3138.244.71%
2019-12-3126.4210.5%
2018-12-318.51-38.54%
2017-12-3113.8-135.14%
2016-12-31-39.4-176.26%
2015-12-3151.676.05%
2014-12-3129.3-134.16%
2013-12-31-85.9-654.8%
2012-12-3115.5-82.89%
2011-12-3190.5131.13%
2010-12-3139.1-49.79%
2009-12-3178.0162.89%
2008-12-3129.7209.28%
2007-12-319.59-60%
2006-12-3124.0298.07%
2005-12-316.02-17.52%
2004-12-317.30
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-20.2-196.55%๐Ÿ‡บ๐Ÿ‡ธ USA
50.8 142.63%๐Ÿ‡บ๐Ÿ‡ธ USA
2.52-87.97%๐Ÿ‡บ๐Ÿ‡ธ USA
1.65-92.13%๐Ÿ‡บ๐Ÿ‡ธ USA
1.79-91.45%๐Ÿ‡ซ๐Ÿ‡ท France
5.48-73.84%๐Ÿ‡บ๐Ÿ‡ธ USA